Most bought healthcare stocks in Q1 2025
See which Healthcare stocks institutional investors increased the most in Q1 2025, measured as net growth in reported share positions from Q4 2024 into Q1 2025. Notable additions at the top of this list include GSK PLC-SPON ADR (GSK), BAXTER INTERNATIONAL INC (BAX), OPTION CARE HEALTH INC (OPCH), GERON CORP (GERN). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| GSK | GSK PLC-SPON ADR | 9,613,303 | $729.76M | 2 | 5 | 4 | 1 | 13 |
| BAX | BAXTER INTERNATIONAL INC | 4,491,031 | $607.39M | 2 | 9 | 5 | 2 | 18 |
| OPCH | OPTION CARE HEALTH INC | 4,374,660 | $156.78M | 3 | 1 | 0 | 1 | 4 |
| GERN | GERON CORP | 4,148,400 | $3.76M | 0 | 1 | 0 | 0 | 1 |
| ZTS | ZOETIS INC | 4,142,497 | $700.85M | 4 | 7 | 9 | 2 | 21 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 3,482,400 | $11.48M | 1 | 0 | 0 | 1 | 1 |
| SENS | SENSEONICS HOLDINGS INC | 3,350,539 | $2.40M | 0 | 1 | 0 | 0 | 2 |
| WBA | WALGREENS BOOTS ALLIANCE INC | 2,702,730 | $33.98M | 3 | 1 | 5 | 2 | 9 |
| ABSI | ABSCI CORP | 2,689,153 | $5.84M | 0 | 1 | 0 | 0 | 1 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 2,575,126 | -$85.29M | 3 | 4 | 2 | 2 | 10 |
| RXRX | RECURSION PHARMACEUTICALS-A | 2,493,358 | -$34.37M | 2 | 2 | 1 | 2 | 5 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 2,485,707 | $126.94M | 3 | 4 | 1 | 2 | 9 |
| CPRX | CATALYST PHARMACEUTICALS INC | 2,304,850 | $65.58M | 3 | 1 | 1 | 1 | 5 |
| ORIC | ORIC PHARMACEUTICALS INC | 2,141,692 | $917.43K | 0 | 1 | 0 | 0 | 1 |
| BAYRY | BAYER AG-SPONSORED ADR | 2,067,470 | $17.58M | 0 | 1 | 0 | 0 | 1 |
| TEM | TEMPUS AI INC | 2,001,609 | $176.48M | 3 | 1 | 0 | 0 | 4 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 1,738,367 | $425.52M | 3 | 3 | 7 | 2 | 16 |
| TALK | TALKSPACE INC | 1,699,850 | $3.19M | 0 | 2 | 0 | 0 | 2 |
| TNYA | TENAYA THERAPEUTICS INC | 1,691,725 | $717.23K | 1 | 1 | 0 | 0 | 3 |
| MYGN | MYRIAD GENETICS INC | 1,655,592 | -$1.53M | 1 | 1 | 1 | 1 | 4 |
| BEAM | BEAM THERAPEUTICS INC | 1,404,261 | -$9.94M | 0 | 2 | 1 | 0 | 3 |
| OCGN | OCUGEN INC | 1,371,651 | $762.75K | 0 | 1 | 0 | 0 | 1 |
| ARDX | ARDELYX INC | 1,351,593 | $6.64M | 1 | 0 | 0 | 0 | 2 |
| WST | WEST PHARMACEUTICAL SERVICES | 1,349,345 | $223.88M | 4 | 2 | 2 | 3 | 10 |
| TXG | 10X GENOMICS INC-CLASS A | 1,332,051 | -$58.28M | 2 | 3 | 0 | 1 | 6 |
| NMRA | NEUMORA THERAPEUTICS INC | 1,259,530 | $1.26M | 1 | 0 | 0 | 0 | 1 |
| OGN | ORGANON & CO | 1,196,030 | $17.61M | 2 | 3 | 2 | 1 | 10 |
| MASI | MASIMO CORP | 1,140,602 | $190.05M | 2 | 0 | 1 | 0 | 4 |
| TDOC | TELADOC HEALTH INC | 1,114,136 | $2.26M | 2 | 2 | 1 | 1 | 7 |
| HRTX | HERON THERAPEUTICS INC | 1,085,700 | $3.19M | 0 | 1 | 0 | 0 | 1 |
| NVST | ENVISTA HOLDINGS CORP | 1,048,004 | -$12.79M | 0 | 3 | 2 | 1 | 5 |
| BIO | BIO-RAD LABORATORIES-A | 1,033,889 | $90.20M | 1 | 4 | 1 | 2 | 7 |
| ILMN | ILLUMINA INC | 1,016,012 | -$51.55M | 2 | 7 | 4 | 1 | 13 |
| ALLO | ALLOGENE THERAPEUTICS INC | 1,002,159 | $1.09M | 0 | 1 | 0 | 0 | 2 |
| AGL | AGILON HEALTH INC | 1,000,890 | $5.57M | 1 | 2 | 1 | 1 | 4 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 940,183 | $871.38K | 0 | 1 | 1 | 0 | 3 |
| GBIO | GENERATION BIO CO | 917,711 | -$259.06K | 0 | 1 | 0 | 0 | 1 |
| OVID | OVID THERAPEUTICS INC | 916,100 | $218.76K | 0 | 1 | 0 | 0 | 1 |
| NVRO | NEVRO CORP | 909,100 | $5.95M | 0 | 1 | 0 | 0 | 1 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 894,005 | $191.16M | 2 | 3 | 3 | 1 | 9 |
| BKD | BROOKDALE SENIOR LIVING INC | 890,844 | $15.10M | 1 | 2 | 0 | 0 | 3 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 874,251 | -$25.55M | 0 | 1 | 0 | 0 | 1 |
| WRBY | WARBY PARKER INC-CLASS A | 859,756 | -$54.35M | 2 | 2 | 2 | 1 | 6 |
| TERN | TERNS PHARMACEUTICALS INC | 810,700 | $505.22K | 0 | 1 | 0 | 0 | 1 |
| CERS | CERUS CORP | 794,181 | -$2.08M | 0 | 1 | 1 | 0 | 3 |
| NKTR | NEKTAR THERAPEUTICS | 790,995 | -$439.82K | 0 | 1 | 0 | 0 | 2 |
| RLAY | RELAY THERAPEUTICS INC | 726,920 | -$419.25K | 0 | 1 | 0 | 0 | 1 |
| CRON | CRONOS GROUP INC | 715,480 | $1.18M | 0 | 1 | 1 | 0 | 3 |
| CVS | CVS HEALTH CORP | 679,158 | $2.27B | 4 | 6 | 8 | 5 | 23 |
| WAY | WAYSTAR HOLDING CORP | 678,524 | $25.37M | 1 | 1 | 0 | 0 | 2 |
Frequently asked questions about Most bought healthcare stocks in Q1 2025
What are the most bought Healthcare stocks in Q1 2025?
The most bought healthcare stocks in Q1 2025 are those with the largest increase in reported share counts across institutional investors compared to Q4 2024, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q1 2025?
Among filers in this sector, net additions were largest in companies such as GSK PLC-SPON ADR (GSK), BAXTER INTERNATIONAL INC (BAX), OPTION CARE HEALTH INC (OPCH), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2024).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.